Smart insulin pump shows promise for faster, safer dosing in type 2 diabetes
NCT ID NCT06024928
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 21 times
Summary
This pilot study tested whether using an automated insulin delivery (AID) system for just 10 days can help people with type 2 diabetes safely adjust their long-acting insulin doses. 23 adults on insulin injections were randomly assigned to use the AID pump or continue their usual care. The goal was to see if the device could improve blood sugar control quickly and safely, with feedback from participants on how well it worked.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Virginia Center for Diabetes Technology
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.